Skip to main content

Advertisement

Log in

Guidelines on Hemolytic Uremic Syndrome by Indian Society of Pediatric Nephrology: Key Messages

  • Update
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Hemolytic uremic syndrome is an important cause of acute kidney injury that requires dialysis in children. The diagnosis and management is difficult due to limited diagnostic facilities and non-availability of specific complement inhibitors. We describe salient features of the recent Indian Society of Pediatric Nephrology consensus guidelines on hemolytic uremic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bagga A, Khandelwal P, Mishra K, Thergaonkar R, Vasudevan A, Sharma J, et al. Hemolytic Uremic Syndrome in a Developing Country: Consensus Guidelines. Pediatr Nephrol. 2019;34:1465–82.

    Article  Google Scholar 

  2. Zini G, d’Onofrio G, Briggs C, Erber W, Jou JM, Lee SH, et al. ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes. Int J Lab Hematol. 2012;34:107–16.

    Article  CAS  Google Scholar 

  3. Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016;31:15–39.

    Article  Google Scholar 

  4. Huemer M, Diodato D, Schwahn B, Schiff M, Bandeira A, Benoist JF, et al. Guidelines for Diagnosis and Management of the Cobalamin-related Remethylation Disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR Deficiency. J Inherit Metab Dis. 2017;40:21–48.

    Article  CAS  Google Scholar 

  5. Sinha A, Gulati A, Saini S, Blanc C, Gupta A, Gurjar BS, et al. Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children. Kidney Int. 2014;85:1151–60.

    Article  CAS  Google Scholar 

  6. Watson R, Lindner S, Bordereau P, Hunze EM, Tak F, Ngo S, et al. Standardisation of the factor H autoantibody assay. Immunobiology. 2014;219:9–16.

    Article  CAS  Google Scholar 

  7. Khandelwal P, Thomas CC, Rathi BS, Hari P, Tiwari AN, Sinha A, et al. Membrane-filtration based plasma exchanges for atypical hemolytic uremic syndrome: Audit of efficacy and safety. J Clin Apher. 2019;34:555–62.

    Article  Google Scholar 

  8. Puraswani M, Khandelwal P, Saini H, Saini S, Gurjar BS, Sinha A, et al. Clinical and immunological profile of antifactor H antibody associated atypical hemolytic uremic syndrome: A nationwide database. Front Immunol. 2019;10:1282.

    Article  CAS  Google Scholar 

  9. Khandelwal P, Gupta A, Sinha A, Saini S, Hari P, Dragon Durey MA, et al. Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome. Pediatr Nephrol. 2015;30:451–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arvind Bagga.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khandelwal, P., Bagga, A. Guidelines on Hemolytic Uremic Syndrome by Indian Society of Pediatric Nephrology: Key Messages. Indian Pediatr 57, 744–747 (2020). https://doi.org/10.1007/s13312-020-1920-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-020-1920-9

Keywords

Navigation